title: Successful rapid rituximab desensitization in an adolescent patient with nephrotic syndrome: Increase in number of Treg cells after desensitization.
authors.forename: Metin
authors.initials: M
authors.lastname: Aydogan
authors.forename: Nail
authors.initials: N
authors.lastname: Yologlu
authors.forename: Gulcin
authors.initials: G
authors.lastname: Gacar
authors.forename: Zeynep Seda
authors.initials: ZS
authors.lastname: Uyan
authors.forename: Isil
authors.initials: I
authors.lastname: Eser
authors.forename: Erdal
authors.initials: E
authors.lastname: Karaoz
mesh_terms: D000293:Adolescent; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage* / Q000009:adverse effects; D003888:Desensitization, Immunologic / Q000379:methods*; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000276:immunology*; D000069283:Rituximab; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab